Advertisement

Topics

UPDATE 1-Bristol's drug cocktail cuts kidney cancer death risk 37 pct

14:21 EDT 10 Sep 2017 | Topix

A combination of two Bristol-Myers Squibb immunotherapy drugs cut the risk of death by 37 percent in a key group of kidney cancer patients, data from a closely watched clinical trial showed on Sunday. The U.S. drugmaker reported three days ago it was ending the trial well ahead of schedule due to its early success in improving overall survival, despite earlier mixed results.

Original Article: UPDATE 1-Bristol's drug cocktail cuts kidney cancer death risk 37 pct

NEXT ARTICLE

More From BioPortfolio on "UPDATE 1-Bristol's drug cocktail cuts kidney cancer death risk 37 pct"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Endocrinology
Diabetes Diabetes Endocrine Obesity Oxycontin Renal Disease Thyroid Disorders Endocrinology is the study of the endocrine glands and the hormones that they secrete (Oxford Medical Dictionary). There are several groups of h...